Emerging targeted treatments for malignant glioma.

about

Multi-Center Randomized Phase II Study Comparing Cediranib plus Gefitinib with Cediranib plus Placebo in Subjects with Recurrent/Progressive Glioblastoma.Three different brain tumours evolving from a common origin

P2860

Q36032533-43D5BDE3-93D3-4AAE-8457-078C8231DB94 Q36809583-9918227C-246D-42B2-8AFC-6E9832FE658B

P2860

Emerging targeted treatments for malignant glioma.

Item

http://www.wikidata.org/entity/Q36302855

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

Emerging targeted treatments for malignant glioma.

@ast

Emerging targeted treatments for malignant glioma.

@en

type

Item

label

Emerging targeted treatments for malignant glioma.

@ast

Emerging targeted treatments for malignant glioma.

@en

prefLabel

Emerging targeted treatments for malignant glioma.

@ast

Emerging targeted treatments for malignant glioma.

@en

P1476

Emerging targeted treatments for malignant glioma.

@en

P2093

Cathryn S Brock

http://www.w3.org/2001/XMLSchema#string

Christina Thirlwell

http://www.w3.org/2001/XMLSchema#string

Edward S Newlands

http://www.w3.org/2001/XMLSchema#string

Paul J Mulholland

http://www.w3.org/2001/XMLSchema#string

P2860

Identification and preliminary characterization of protein-cysteine farnesyltransferase

In vivo activation of the p53 pathway by small-molecule antagonists of MDM2

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

The protein tyrosine kinase family of the human genome

Regulation of HDM2 activity by the ribosomal protein L11

Activation of the MAP kinase pathway by the protein kinase raf

PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials.

Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome.

P304

845-854

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14728214.10.4.845

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2005-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16262566

http://www.w3.org/2001/XMLSchema#string

Emerging targeted treatments for malignant glioma.

about

P2860

P2860

Emerging targeted treatments for malignant glioma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698